Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,093,218
  • Shares Outstanding, K 390,734
  • Annual Sales, $ 3,236 M
  • Annual Income, $ -3,561 M
  • EBIT $ -3,463 M
  • EBITDA $ -3,369 M
  • 60-Month Beta 1.11
  • Price/Sales 3.68
  • Price/Cash Flow N/A
  • Price/Book 1.28

Options Overview Details

View History
  • Implied Volatility 61.88% (-0.67%)
  • Historical Volatility 59.91%
  • IV Percentile 15%
  • IV Rank 15.54%
  • IV High 104.55% on 04/08/25
  • IV Low 54.03% on 08/06/25
  • Expected Move (DTE 7) 1.55 (4.58%)
  • Put/Call Vol Ratio 0.68
  • Today's Volume 122,203
  • Volume Avg (30-Day) 80,158
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 1,071,890
  • Open Int (30-Day) 1,004,884
  • Expected Range 32.25 to 35.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -2.79
  • Number of Estimates 9
  • High Estimate -2.33
  • Low Estimate -3.15
  • Prior Year -2.50
  • Growth Rate Est. (year over year) -11.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.28 +51.71%
on 11/21/25
34.25 -1.31%
on 12/19/25
+9.62 (+39.78%)
since 11/19/25
3-Month
22.28 +51.71%
on 11/21/25
34.25 -1.31%
on 12/19/25
+8.56 (+33.91%)
since 09/19/25
52-Week
22.28 +51.71%
on 11/21/25
48.92 -30.91%
on 01/07/25
-5.76 (-14.56%)
since 12/19/24

Most Recent Stories

More News
Why Is Moderna (MRNA) Stock Rocketing Higher Today

Why Is Moderna (MRNA) Stock Rocketing Higher Today

MRNA : 33.80 (+9.21%)
Why Moderna (MRNA) Stock Is Up Today

Why Moderna (MRNA) Stock Is Up Today

MRNA : 33.80 (+9.21%)
CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure

MRNA : 33.80 (+9.21%)
Moderna (MRNA) Stock Trades Up, Here Is Why

Moderna (MRNA) Stock Trades Up, Here Is Why

MRNA : 33.80 (+9.21%)
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p.m....

MRNA : 33.80 (+9.21%)
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)

mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)

MRNA : 33.80 (+9.21%)
3 Cash-Burning Stocks We Steer Clear Of

3 Cash-Burning Stocks We Steer Clear Of

UPST : 47.59 (+1.19%)
PRPL : 0.7460 (-3.18%)
MRNA : 33.80 (+9.21%)
Option Volatility and Earnings Report for December 8 - 12

Earnings season is starting to wind down but we still have some big names due to report Q3 numbers. This week, we have Costco (COST), Broadcom (AVGO), Adobe Systems (ADBE) and Oracle (ORCL) all set to...

NFLX : 94.39 (+0.41%)
COST : 855.62 (-0.23%)
AVGO : 340.36 (+3.18%)
SMCI : 31.11 (+5.92%)
NOW : 155.31 (+1.26%)
ADBE : 355.86 (+0.01%)
ORCL : 191.97 (+6.63%)
MRNA : 33.80 (+9.21%)
AAL : 15.78 (+1.09%)
COIN : 245.12 (+2.47%)
Why Is Moderna (MRNA) Stock Rocketing Higher Today

Why Is Moderna (MRNA) Stock Rocketing Higher Today

MRNA : 33.80 (+9.21%)
The Mid-Week Brief: Labor Market Cracks as Small-Caps Stage Comeback

The narrative on Wall Street shifted dramatically this week. What began as a post-holiday hangover on Monday has evolved into a full-blown “bad news is good news” rally by Thursday morning. The catalyst?...

GOOGL : 307.16 (+1.55%)
AAPL : 273.67 (+0.54%)
AVGO : 340.36 (+3.18%)
DG : 137.28 (+0.44%)
COIN : 245.12 (+2.47%)
MSFT : 485.92 (+0.40%)
^DOGEUSD : 0.132453 (+0.29%)
PSTG : 69.13 (+3.09%)
TSLA : 481.20 (-0.45%)
IRBT : 0.4700 (-29.51%)
^BTCUSD : 88,146.15 (+0.35%)
GME : 22.51 (-0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 38.06
2nd Resistance Point 36.15
1st Resistance Point 34.98
Last Price 33.80
1st Support Level 31.90
2nd Support Level 29.99
3rd Support Level 28.82

See More

52-Week High 48.92
Fibonacci 61.8% 38.74
Fibonacci 50% 35.60
Last Price 33.80
Fibonacci 38.2% 32.46
52-Week Low 22.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar